Genomics is Not Left for Dead, Despite Where it’s Trading

April 27, 2022

Genomics is Not Left for Dead, Despite Where it’s Trading

Genomics companies have been all the rage over the last few years as technologies like next gen sequencing and cancer testing have been capturing...

Tecan: Enabling the disruption of life science and diagnostics

June 28, 2019

Tecan: Enabling the disruption of life science and diagnostics

At a recent visit to our New York office, Achim von Leoprechting, the new CEO of Switzerland-based Tecan, shared how the Swiss company’s technology...

1